Evidence map›Paper›PMID 26305100›Full record

ArticlePLoS pathogens2015

Type VI Secretion System Toxins Horizontally Shared between Marine Bacteria.

Dor Salomon, John A Klimko, David C Trudgian, Lisa N Kinch, Nick V Grishin, Hamid Mirzaei, Kim Orth

Abstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. Review
  3. Frontiers in veterinary science · 2026
    Review
  4. The multifunctional type VI secretion system ofApplied and environmental microbiology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Journal of bacteriology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. PandemicLife science alliance · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dor SalomonDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
John A KlimkoDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
David C TrudgianDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Lisa N KinchHoward Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Nick V GrishinDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Hamid MirzaeiDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Kim OrthDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

Funding

Biochemical Characterization of Yersinia Effector YopJ.R01AI056404 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI ORTH, KIM · 2003 to 2012
$2.8M
Computational methods for structural-functional studies of proteinsR01GM094575 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI GRISHIN, NICK V. · 2010 to 2017
$2.4M
Type VI Secretion System MIX-effectors and their use as anti-bacterial agentsK99AI116948 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SALOMON, DOR SAMUEL · 2015 to 2015
$84k
NIAID NIH HHS K99 AI116948NIAID NIH HHS K99AI116948NIAID NIH HHS R01 AI056404NIAID NIH HHS R01-AI056404NIGMS NIH HHS GM094575NIGMS NIH HHS R01 GM094575
6 · The paper itself

Abstract

The type VI secretion system (T6SS) is a widespread protein secretion apparatus used by Gram-negative bacteria to deliver toxic effector proteins into adjacent bacterial or host cells. Here, we uncovered a role in interbacterial competition for the two T6SSs encoded by the marine pathogen Vibrio alginolyticus. Using comparative proteomics and genetics, we identified their effector repertoires. In addition to the previously described effector V12G01_02265, we identified three new effectors secreted by T6SS1, indicating that the T6SS1 secretes at least four antibacterial effectors, of which three are members of the MIX-effector class. We also showed that the T6SS2 secretes at least three antibacterial effectors. Our findings revealed that many MIX-effectors belonging to clan V are "orphan" effectors that neighbor mobile elements and are shared between marine bacteria via horizontal gene transfer. We demonstrated that a MIX V-effector from V. alginolyticus is a functional T6SS effector when ectopically expressed in another Vibrio species. We propose that mobile MIX V-effectors serve as an environmental reservoir of T6SS effectors that are shared and used to diversify antibacterial toxin repertoires in marine bacteria, resulting in enhanced competitive fitness.

Indexed as

Amino Acid SequenceBacterial ToxinsBase SequenceGenes, BacterialGenetic FitnessGene Transfer, HorizontalMass SpectrometryMolecular Sequence DataType VI Secretion SystemsVibrio alginolyticusBacterial ToxinsType VI Secretion Systems

Identifiers

PMID26305100
PMCPMC4549250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.